Denmark: DanCann Pharma appoints Martin Vedel Ernst as new CFO

DanCann Pharma, a Danish cannabinoid company, has appointed Martin Vedel Ernst as its new CFO. He replaces Mads Møller Kristensen, who leaves the company at the end of May after serving as CFO for two years. DanCann Pharma’s future financial tasks will be handled by Ernst, who has business experience from jobs as an accountant…

You must be a HMI Subscriber to view this content.

Subscribe Now »